Enlightenment through smart measurements

Open menu

News & Events

Conference Call Q3

13 July 2021

OpSens Announces Third Quarter Fiscal 2021 Record Financial Results

13 July 2021

OpSens Announces Third Quarter Fiscal 2021 Record Financial Results Conference call on the results to be held today at 11 a.m. Quebec City, Quebec, July 13, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, today reported its…

Read more

OpSens to Host Third Quarter Fiscal Year 2021 Financial Results Conference Call on Tuesday, July 13

7 July 2021

OpSens to Host Third Quarter Fiscal Year 2021 Financial Results Conference Call on Tuesday, July 13, 2021  Conference call to be conducted at 11:00 am ET Quebec City, Quebec, July 7, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical…

Read more

OpSens Solutions Receives Funding Support to Jointly Develop an Optical-Based Fuel Monitoring System for Aerospace Applications, Including Civil Aircrafts

16 June 2021

OpSens Solutions Receives Funding Support to Jointly Develop an Optical-Based Fuel Monitoring System for Aerospace Applications, Including Civil Aircrafts Quebec City, Quebec, June 16, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that OpSens Solutions Inc. (“OpSens Solutions”), its wholly-owned subsidiary, is receiving advisory services and up to $500,000 in funding support…

Read more

OpSsens Will Participate and Present at Two Investment Conferences Lytham Partners and Raymond James

9 June 2021

OPSENS WILL PARTICIPATE AND PRESENT AT TWO INVESTMENT CONFERENCES Lytham Partners and Raymond James Quebec City, Quebec, June 9, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF),  a medical device cardiology-focused company commercializing a  second-generation fiber optic pressure guidewire to diagnose and treat coronary artery disease, announced today that it will present at…

Read more

OpSens to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference

13 May 2021

OpSens to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference Presentation at 11:30 a.m. ET on Wednesday, May 19, 2021 Quebec City, Quebec, May 13, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF),  a medical device cardiology-focused company commercializing a  second-generation fiber optic pressure guidewire to diagnose…

Read more

OPSENS INTEGRATES ITS OPTOWIRE’S dPR AND FFR ALGORITHMS WITHIN CATHMEDICAL CARDIOVASCULAR’S PICASSO SYSTEM IN SPAIN

21 April 2021

OpSens INTEGRATES ITS OPTOWIRE’S dPR AND FFR ALGORITHMS WITHIN CATHMEDICAL CARDIOVASCULAR’s PICASSO SYSTEM IN SPAIN Agreement Allows Cardiologists to Perform dPR and FFR Procedures Using OpSens’ OptoWire and Cathmedical’s Picasso System in an Integrated Fashion Quebec City, Quebec, April 21, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF),  a medical device cardiology-focused company, today announced…

Read more

OpSens Announces Q2 Fiscal 2021 Financial Results and Record FFR and dPR Revenues

14 April 2021

  OpSens Announces Q2 Fiscal 2021 Financial Results and Record FFR and dPR Revenues Quebec City, Quebec, April 14, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, today reported its financial results for the second quarter of fiscal…

Read more

OpSens AWARDED INNOVATIVE TECHNOLOGY CONTRACT BY VIZIENT FOR OPTOWIRE III

7 April 2021

OPSENS AWARDED INNOVATIVE TECHNOLOGY CONTRACT BY VIZIENT FOR OPTOWIRE III  Contract awarded for products that bring improvement to health care industry   Quebec City, Quebec, April 7, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company, announced today it has been awarded an Innovative Technology  contract from Vizient, Inc.,…

Read more

OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021 – Conference call to be conducted at 11:00 am ET

6 April 2021

OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021 Conference call to be conducted at 11:00 am ET Quebec City, Quebec, April 6, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical…

Read more